AstraZeneca (GB:AZN) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
AstraZeneca remains committed to delivering its innovative medicines in China despite ongoing investigations, which the company is prepared to cooperate with if requested by authorities. The biopharmaceutical giant continues its operations, focusing on its core areas including Oncology and BioPharmaceuticals, across more than 125 countries.
For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.
